Clinical Trials Browser

Interventional × Procarbazine × Clear all

NCT07015242 2026-03-11

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Phase 2 Recruiting

Lymphoma

NCT05331521 2026-02-03

ImproveCodel

Phase 3 Recruiting

Oligodendroglioma

NCT00887146 2026-01-22

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

Phase 3 Active not recruiting

Astrocytoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00002462 2025-08-05

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

Phase 3 Active not recruiting

Hodgkin Disease, Lymphoma

NCT00049595 2025-08-05

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

Phase 3 Completed

Hodgkin Disease, Lymphoma

NCT00379041 2025-08-05

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

Phase 3 Active not recruiting

Hodgkin Disease, Lymphoma

NCT03495960 2025-01-30

FIORELLA

Phase 2 Completed

Lymphoma, Non-Hodgkin

NCT00003375 2024-07-09

Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma

Phase 2/3 Completed

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00678327 2024-05-08

Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

Phase 3 Completed

Hodgkin Disease, Lymphoma

NCT00596154 2024-04-01

PCNSL

Phase 2 Completed

33 enrolled 9 charts

Lymphoma, Non-Hodgkin

NCT03576378 2024-02-26

BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)

Phase 1/2 Unknown

Hodgkin Disease

NCT00574496 2023-09-28

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

Phase 2 Completed

25 enrolled 10 charts

Hodgkin Disease, Lymphoma, Recurrence

NCT01399372 2023-07-20

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Phase 2 Completed

91 enrolled 17 charts

Lymphoma, Radiation Injuries, Neurotoxicity Syndromes

NCT00335140 2023-07-03

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

Phase 2 Terminated

26 enrolled 11 charts

Lymphoma

NCT01390584 2023-06-29

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Phase 2 Terminated

6 enrolled 9 charts

Hodgkin Disease, Lymphoma

NCT01775475 2022-10-10

Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma

Phase 2 Completed

7 enrolled 14 charts

Lymphoma, AIDS-Related

NCT00079092 2021-09-09

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT02298283 2021-07-26

BRAPP2

Phase 2 Completed

Hodgkin Disease

NCT01132807 2021-06-14

Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Phase 2 Completed

164 enrolled 7 charts

Hodgkin Disease, Lymphoma

NCT00577993 2020-11-16

Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients

Phase 3 Completed

210 enrolled 14 charts

Lymphoma, Lymphoma, Follicular

NCT01356680 2020-04-06

HD17 for Intermediate Stage Hodgkin Lymphoma

Phase 3 Completed

Hodgkin Disease

NCT00416832 2020-03-26

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma

NCT00433459 2020-03-26

Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Phase 3 Completed

Hodgkin Disease, Lymphoma

NCT01569204 2018-10-29

Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma

Phase 2 Completed

Hodgkin Disease

NCT00002569 2018-06-18

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Phase 3 Completed

Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00074191 2017-04-21

Protocol-A

Phase 2 Completed

Lymphoma, Intraocular Lymphoma

NCT00594815 2017-04-06

Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Phase NA Completed

52 enrolled 8 charts

Lymphoma

NCT00079105 2017-03-30

A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years

Phase 2 Completed

Hodgkin Disease, Lymphoma

NCT00002806 2016-07-13

Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma

Phase 2 Completed

Astrocytoma, Central Nervous System Neoplasms

NCT00592111 2015-12-23

A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)

Phase 2 Completed

Hodgkin Disease

NCT00795613 2015-10-19

HD0607

Phase 2 Unknown

Hodgkin Disease

NCT00187057 2015-08-27

Study for Treatment of Cancer in Children With Ataxia-telangiectasia

Phase NA Completed

Ataxia, Ataxia Telangiectasia

NCT01251107 2015-08-13

Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma

Phase 3 Completed

Hodgkin Disease

NCT00005796 2015-03-25

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Phase 1 Completed

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT00666484 2014-12-04

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

Phase 2 Completed

Hodgkin Disease, Lymphoma, Neurotoxicity Syndromes

NCT01130194 2014-05-12

MasterPlan

Phase 2 Completed

Lymphoma, Follicular

NCT00004010 2014-02-26

Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease

Phase 2 Completed

Hodgkin Disease, Lymphoma

NCT00052455 2013-12-18

Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma

Phase 3 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00003788 2013-11-06

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

Phase 3 Unknown

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00002944 2013-09-09

Combination Chemotherapy in Treating Children With Progressive Brain Tumors

Phase 3 Completed

Astrocytoma, Brain Neoplasms, Central Nervous System Neoplasms, Optic Nerve Glioma

NCT00025064 2013-08-07

Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma

Phase 2 Unknown

Lymphoma, Recurrence

NCT00416377 2013-08-02

Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Phase NA Unknown

Lymphoma, Recurrence

NCT00417014 2013-08-02

Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma

Phase NA Unknown

Lymphoma, Recurrence

NCT00003101 2013-06-25

Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

Phase 2 Completed

Oligodendroglioma, Central Nervous System Neoplasms

NCT00004004 2013-06-21

Procarbazine in Treating Patients With Recurrent Brain Tumor

Phase 1/2 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00002463 2013-02-18

Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors

Phase 2 Completed

Astrocytoma, Central Nervous System Neoplasms

NCT01737346 2012-12-03

Procarbazine and Lomustine in Recurrent Glioblastoma

Phase 2 Unknown

Glioblastoma, Recurrence

NCT00003293 2012-09-11

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Phase 3 Completed

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00002840 2012-07-10

Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma

Phase 3 Completed

Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00734773 2012-05-18

Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL

Phase EARLY_PHASE1 Withdrawn

Lymphoma, Central Nervous System Neoplasms, Neurotoxicity Syndromes